Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

neuroendocrine

  • You have access
    68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
    Stephen A. Deppen, Jeffrey Blume, Adam J. Bobbey, Chirayu Shah, Michael M. Graham, Patricia Lee, Dominique Delbeke and Ronald C. Walker
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 872-878; DOI: https://doi.org/10.2967/jnumed.115.165803
  • You have access
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
    Stephen A. Deppen, Eric Liu, Jeffrey D. Blume, Jeffrey Clanton, Chanjuan Shi, Laurie B. Jones-Jackson, Vipul Lakhani, Richard P. Baum, Jordan Berlin, Gary T. Smith, Michael Graham, Martin P. Sandler, Dominique Delbeke and Ronald C. Walker
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 708-714; DOI: https://doi.org/10.2967/jnumed.115.163865
  • You have access
    The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
    Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn
    Journal of Nuclear Medicine December 1, 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780
  • You have access
    High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation
    Haïfa Bahri, Lenoir Laurence, Julien Edeline, Houda Leghzali, Anne Devillers, Jean-Luc Raoul, Marc Cuggia, Habiba Mesbah, Bruno Clement, Eveline Boucher and Etienne Garin
    Journal of Nuclear Medicine November 1, 2014, 55 (11) 1786-1790; DOI: https://doi.org/10.2967/jnumed.114.144386
  • You have access
    18F-Fluorodihydroxyphenylalanine PET/CT in Patients with Neuroendocrine Tumors of Unknown Origin: Relation to Tumor Origin and Differentiation
    Alessio Imperiale, Edmond Rust, Sophie Gabriel, Julien Detour, Bernard Goichot, Bernard Duclos, Jean-Emmanuel Kurtz, Philippe Bachellier, Izzie-Jacques Namer and David Taïeb
    Journal of Nuclear Medicine March 1, 2014, 55 (3) 367-372; DOI: https://doi.org/10.2967/jnumed.113.126896

Pages

  • Previous
  • 1
  • 2
  • 3
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire